The first 6 months of US data after nearly 300 million doses show results consistent with preauthorization trials and early post-authorization surveillance. About 1 in 1000 have an adverse effect.
Medscape Medical News
…read more
The first 6 months of US data after nearly 300 million doses show results consistent with preauthorization trials and early post-authorization surveillance. About 1 in 1000 have an adverse effect.
Medscape Medical News
…read more